Published in
Elsevier, Clinical Breast Cancer, 5(16), p. 349-355
DOI: 10.1016/j.clbc.2016.05.006
Links
Tools
Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial
Journal article published in 2016 by
Denise A. Yardley,
Patrick J. Ward 
,
Brooke R. Daniel,
Janice F. Eakle,
Ruth E. Lamar,
Cassie M. Lane,
John D. Hainsworth
,
Brooke R. Daniel,
Janice F. Eakle,
Ruth E. Lamar,
Cassie M. Lane,
John D. Hainsworth
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 